Icon

PANHEPRIN (nda005264)- (1,000 UNITS/ML,5,000 UNITS/ML,10,000 UNITS/ML,20,000 UNITS/ML,40,000 UNITS/ML)

HEPARIN SODIUM HOSPIRA
1,000 UNITS/ML,5,000 UNITS/ML,10,000 UNITS/ML,20,000 UNITS/ML,40,000 UNITS/ML
No No
Expired Expired
None None
None No
Heparin Sodium Injection, USP is indicated for: • Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; • Low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; • Prophylaxis and treatment of pulmonary embolism; • Atrial fibrillation with embolization; • Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); • Prevention of clotting in arterial and cardiac surgery; • Prophylaxis and treatment of peripheral arterial embolism; • Heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation and dialysis procedures.
0 0 0
Total Other Developers None
Drugs with Suitability No
1,000 UNITS/ML ** ** - - -
5,000 UNITS/ML ** ** - - -
10,000 UNITS/ML ** ** - - -
20,000 UNITS/ML ** ** - - -
40,000 UNITS/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.